US Biomax - Endocrine Cancer Tissue Array, Including TNM And Clinical Stage, 40 Cases/80 Cores, Replacing EN801

Endocrine Sub-types (4)

Paraffin Embedded Tissue Array Types [view all]

Human

EN801a

Endocrine cancer tissue array, including TNM and clinical stage, 40 cases/80 cores, replacing EN801

Unstained: $255.00

H&E (EN801as*): $255.00

Microarray Panel:	Endocrine carcinoma tissue microarray, containing 40 cases of endocrine cancer (10 adrenal cortical adenocarcinoma, 4 pancreatic islet cell carcinoma, 2 each of esophageal and cardia neuroendocrine carcinoma, 3 gastric carcinoid, 1 each of colon neuroendocrine, small intestine carcinoid and rectum carcinoid, 12 lung atypical carcinoid and 4 lung carcinoid), duplicate cores per case
Cores:	80
Cases:	40
Layout:	10 cols × 8 rows
Core Diameter:	1.5 mm
Thickness:	5 µm
Quality Control:	Anti-Actin confirmed
Applications:	Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:	Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

Unstained: unstained paraffin tissue microarray slide.
Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

Slide Label: US Biomax, Inc. Tissue Array

	1	2	3	4	5	6	7	8	9	10
A
B
C
D
E
F
G
H

Legend:

Adr - Adrenal gland, Car - Cardia, Col - Colon, Eso - Esophagus, Lun - Lung, Pan - Pancreas, Rec - Rectum, Sma - Small intestine, Sto - Stomach

- Malignant tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIa), - Malignant tumor (stage Ib)

Specification Sheet

Pos	No.	Sex	Age	Organ	Pathology diagnosis	Stage	TNM	Type †
A1	1	M	44	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A2	2	M	44	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A3	3	F	48	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A4	4	F	48	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A5	5	F	53	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A6	6	F	53	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A7	7	M	45	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A8	8	M	45	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A9	9	F	10	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
A10	10	F	10	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B1	11	M	45	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B2	12	M	45	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B3	13	M	58	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B4	14	M	58	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B5	15	M	35	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B6	16	M	35	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B7	17	M	59	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B8	18	M	59	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B9	19	M	54	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
B10	20	M	54	Adrenal gland	Adrenal cortical adenocarcinoma	–	–	Malignant
C1	21	F	52	Pancreas	Islet cell carcinoma	–	–	Malignant
C2	22	F	52	Pancreas	Islet cell carcinoma	–	–	Malignant
C3	23	F	15	Pancreas	Islet cell carcinoma	–	–	Malignant
C4	24	F	15	Pancreas	Islet cell carcinoma	–	–	Malignant
C5	25	F	40	Pancreas	Islet cell carcinoma	–	–	Malignant
C6	26	F	40	Pancreas	Islet cell carcinoma	–	–	Malignant
C7	27	F	16	Pancreas	Islet cell carcinoma	–	–	Malignant
C8	28	F	16	Pancreas	Islet cell carcinoma	–	–	Malignant
C9	29	F	53	Esophagus	Neuroendocrine carcinoma with necrosis	IIa	T2N0M0	Malignant
C10	30	F	53	Esophagus	Neuroendocrine carcinoma (tumoral necrosis)	IIa	T2N0M0	Malignant
D1	31	M	55	Esophagus	Neuroendocrine carcinoma	I	T1N0M0	Malignant
D2	32	M	55	Esophagus	Neuroendocrine carcinoma	I	T1N0M0	Malignant
D3	33	M	68	Cardia	Neuroendocrine carcinoma	IIIa	T3N1M0	Malignant
D4	34	M	68	Cardia	Neuroendocrine carcinoma	IIIa	T3N1M0	Malignant
D5	35	M	68	Cardia	Neuroendocrine carcinoma	IIIa	T3N1M0	Malignant
D6	36	M	68	Cardia	Neuroendocrine carcinoma	IIIa	T3N1M0	Malignant
D7	37	M	50	Stomach	Carcinoid	IIIa	T4N0M0	Malignant
D8	38	M	50	Stomach	Carcinoid	IIIa	T4N0M0	Malignant
D9	39	F	64	Stomach	Carcinoid	Ib	T2N0M0	Malignant
D10	40	F	64	Stomach	Carcinoid	Ib	T2N0M0	Malignant
E1	41	F	52	Stomach	Carcinoid	Ib	T2N0M0	Malignant
E2	42	F	52	Stomach	Carcinoid	Ib	T2N0M0	Malignant
E3	43	F	63	Colon	Neuroendocrine carcinoma	II	T3N0M0	Malignant
E4	44	F	63	Colon	Neuroendocrine carcinoma	II	T3N0M0	Malignant
E5	45	M	57	Small intestine	Carcinoid	II	T2N0M0	Malignant
E6	46	M	57	Small intestine	Carcinoid	II	T2N0M0	Malignant
E7	47	F	70	Rectum	Carcinoid	II	T3N0M0	Malignant
E8	48	F	70	Rectum	Carcinoid	II	T3N0M0	Malignant
E9	49	M	53	Lung	Atypical carcinoid	I	T2N0M0	Malignant
E10	50	M	53	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F1	51	M	57	Lung	Atypical carcinoid	I	T1N0M0	Malignant
F2	52	M	57	Lung	Atypical carcinoid	I	T1N0M0	Malignant
F3	53	M	60	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F4	54	M	60	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F5	55	M	67	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F6	56	M	67	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F7	57	M	60	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F8	58	M	60	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F9	59	M	53	Lung	Atypical carcinoid	I	T2N0M0	Malignant
F10	60	M	53	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G1	61	M	58	Lung	Atypical carcinoid	II	T2N1M0	Malignant
G2	62	M	58	Lung	Atypical carcinoid	II	T2N1M0	Malignant
G3	63	M	64	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G4	64	M	64	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G5	65	M	72	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G6	66	M	72	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G7	67	F	75	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G8	68	F	75	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G9	69	M	59	Lung	Atypical carcinoid	I	T2N0M0	Malignant
G10	70	M	59	Lung	Atypical carcinoid	I	T2N0M0	Malignant
H1	71	M	71	Lung	Carcinoid	I	T2N0M0	Malignant
H2	72	M	71	Lung	Carcinoid	I	T2N0M0	Malignant
H3	73	F	48	Lung	Carcinoid	I	T2N0M0	Malignant
H4	74	F	48	Lung	Carcinoid	I	T2N0M0	Malignant
H5	75	F	52	Lung	Carcinoid	I	T2N0M0	Malignant
H6	76	F	52	Lung	Carcinoid	I	T2N0M0	Malignant
H7	77	M	42	Lung	Atypical carcinoid	II	T2N1M0	Malignant
H8	78	M	42	Lung	Atypical carcinoid	II	T2N1M0	Malignant
H9	79	M	39	Lung	Carcinoid	I	T2N0M0	Malignant
H10	80	M	39	Lung	Carcinoid	I	T2N0M0	Malignant
–	–	M	42	Adrenal gland	Pheochromocytoma (tissue marker)			Malignant

† For precise diagnosis, refer to pathology description.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:

Paraffin Embedded Tissue Array Types [view all]

Human

Cell Arrays (2)

Mouse (16)

Rat (9)

Monkey (5)

Frozen Tissue Arrays (52)

EN801a

*Tissue Microarray Slide Types:

Microarray Panel Display

Specification Sheet

TNM grading: